Pharmaceutical companies just raised list prices for over 500 medicines, including Novo Nordisk’s Ozempic, Gilead’s HIV-1 ...

Nurix Therapeutics (NRIX) leads in targeted protein modulation with its DELigase platform, developing BTK degraders like ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

The highly anticipated 2024-2025 Global Top Brands Award Ceremony and International Consumer Electronics Industry Leaders' Summit were held on January 8, 2025 local time, at the Wynn & Encore Hotel in ...

CREO, the preferred consultancy to the world's most promising life sciences companies seeking to improve human health, announced today four leadership appointments designed to support the company's ...

New attention means new dollars for research and development and investors are betting on the companies that will turn out new products ... hope for a vaccine from Gilead Sciences (NASDAQ ...

These companies focused as much on cod liver oil, toothpaste, citric acid for soft drinks, and hair gel as on prescription medicines, as well as selling products ... The list of novel drugs ...

Technology is advancing at a rapid pace, transforming all areas of our lives and leaving barely any aspect of it unimpacted.  This is not a new phenomenon by any degree. Many centuries ago, the ...

LEO Pharma may receive tiered royalties ranging from high single-digit to mid-teens on sales of topical STAT6 products. The transaction is expected to reduce Gilead's GAAP and non-GAAP 2025 ...

Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...

Gilead's chief executive calls lenacapavir a once in a decade medicine. The HIV treatment could push Gilead stock further up ...

(Reuters) - Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs ...